57.45. Rhenman Healthcare Equity Long Short Fund -. RC2 SEK. Rhenman & Partners Asset. Management. Long/Short Equity. 50.67. Capra Capital Fund.

2020-09-11 · The Rhenman Healthcare Equity Long/Short Fund – which trades a range of small, medium and large pharmaceuticals, biotechnology, medical technology and service company names – added 4 per cent in its euro-denominated class in August. Its SEK share class meanwhile returned 3.75 per cent for the month, with the fund now up 3.5 per cent year-to-date.

27.12. Yong Rong Global Excellence Fund. Yong Rong Asset Management. 69.90%. 210. Rhenman Healthcare Equity Long/Short Fund - USD. Rhenman & Partners Rhenman & Partners Asset Management is a niche player, focused on the healthcare sector. The Stockholm-based firm Hedge Funds, 1, Long/Short Equity 57.45.

Rhenman healthcare long short

Rhenman Healthcare Eq L/S - The objective of the Sub-Fund is to generate a consistent total return above the return generated by traditional investment vehicles through investments in long/short equity strategies. Its flagship healthcare-focused hedge fund finished the first quarter up 5.56 per cent, as a rotation into cyclical equities which stand to gain from the economic recovery underpinned March’s positive returns. The Rhenman Healthcare Equity Long/Short strategy advanced 3.6 per cent in its main euro-denominated IC1 share class last month. Rhenman Healthcare Equity L/S (RHELS) is a long-biased sector long/short equity fund investing in the global healthcare market.

Healthcare hedge fund Rhenman gauges “crucial” impact of Biden administration’s planned reforms Submitted By Hugh Leask | 14/01/2021 - 1:07pm The incoming US administration led by Joe Biden will be a “crucial” factor looming large over the healthcare industry this year, with planned reforms heralding potentially far-reaching implications for healthcare stocks and drug prices, Rhenman 2009-08-04 · The trio behind the fund are Henrik Rhenman, who has more than 15 years' experience of managing healthcare funds and is also chief investment officer, Göran Nordström, the former chief executive of Carnegie Asset Management, and myself, a former portfolio strategist at Fidelity Investments. Rhenman Healthcare Equity L/S RC1 SEK. Översikt Historik Betyg & risk Fondfakta Hållbarhet Kategori Obtenga información sobre el fondo Rhenman Healthcare Equity Long/short Rc1 Sek (0P0000KGRO): activos totales, calificación crediticia, inversión mínima y más.

Rhenman & Partners starts new fund: Rhenman Global Opportunities L/S Mon, May 09, 2016 08:00 CET. An active long / short equity mandate with the goal of generating 7-8% annual net return Rhenman & Partners Asset Management will on May 31, 2016 start a new global equity L/S fund - Rhenman Global Opportunities L / S - which can invest in all sectors worldwide.

61%. 0,95. Rhenman Healthcare.

Rhenman Healthcare Equity L/S has an unprecedented performance history since its inception in June 2009.The main unit class, IC1 (EUR), has increased by 695 percent in total, which corresponds to

Fonden är diversifierad i fråga om såväl storleken på de investerade bolagen Placeringsinriktning: Rhenman Healthcare Equity Long/Short RC2 SEK. Fonden är en global hedgefond med fokus på hälsosektorn, framförallt läkemedel, medicinsk teknik, bioteknik och vård. Fonden förvaltas aktivt och fondförvaltaren besitter mer än 15 års förvaltningserfarenhet inom hälsosektorn. Fonden är diversifierad i fråga om såväl storleken på Rhenman Healthcare Equity L/S("RHE L/S") RHE L/S is a global, long-biased hedge fund that invests in the healthcare sector. Since RHE L/S was launched in June 2009, it has returned + 724 %, which corresponds to an annual average of + 20 %.

This Fund Manager Rating is based on the Citywire Absolute Return ratings methodology Alternative UCITS - Long/Short Equity Please see terms and conditions for restrictions on use of Citywire's Fund Manager database. This Fund Manager Rating is based on the Citywire Absolute Return ratings methodology An active long / short equity mandate with the goal of generating 7-8% annual net return. Rhenman & Partners Asset Management will on August 31, 2016, start a new global equity L/S fund - Rhenman Global Opportunities L / S - which can invest in all sectors worldwide. An active long / short equity mandate with the goal of generating 7-8% annual net return Rhenman & Partners Asset Management will on August 31, 2016, start a new global equity L/S fund - Rhenman Rhenman & Partners vinner internationellt fondpris vid Hedgeweek European Awards: Best Global Equity Hedge Fund fre, mar 12, 2021 06:00 CET. Europeiska institutionella investerare, high net worth individuals, placeringsrådgivare, fondförvaltare och prime brokers har röstat fram fonden Rhenman Healthcare Equity L/S till vinnare av Hedgeweek European Awards 2021 i kategorin ”Best Global View Monthly-Report-Rhenman-Global-Opportunities-LS-201803-ENG1.pdf from ENG 1 at ESSCA.
Nacka närakut kontakt

Stockholmsbaserad kapitalförvaltare med fonden Rhenman Healthcare Equity L/ S (RHE Portfolio Manager. Rhenman & Partners Asset Management. maj 2017 –nu4 år.

Rhenman Healthcare Equity Long/Short Fund - USD. Rhenman & Partners Rhenman & Partners Asset Management is a niche player, focused on the healthcare sector. The Stockholm-based firm Hedge Funds, 1, Long/Short Equity 57.45.
Skydda dina personuppgifter

elevassistent utbildning distans
coop giraffen öppettider
hsb brf magelungen i stockholm
zakrisson data hallsberg
anna robinson weakest link
glömt mitt bankid
automatiserad aktiehandel

Stockholm (HedgeNordic) – Rhenman & Partners, the fund management company behind the award-winning Rhenman Healthcare Equity L/S fund which is managed by Henrik Rhenman (pictured), aims to launch a new global long/short equity hedge fund investing across all sectors according to a news release from the manager. The fund is planned to launch on June 1,Read More

To achieve the investment objective, the Sub-Fund will invest in a global portfolio of equities, equity related derivatives, equity index derivatives and other equity related Stockholm (HedgeNordic) – Rhenman & Partners, the fund management company behind the award-winning Rhenman Healthcare Equity L/S fund which is managed by Henrik Rhenman (pictured), aims to launch a new global long/short equity hedge fund investing across all sectors according to a news release from the manager. The fund is planned to launch on June 1,Read More In early 2012, Henrik Rhenman told The Hedge Fund Journal “Either the world is approaching apocalypse, or we are due a massive rally” and he has been vindicated in spades: the Rhenman Healthcare equity long/short fund has delivered returns of more than 200% since the start of 2012. This has been achieved within a robust framework of risk controls. Rhenman Healthcare Equity L/S (RHELS) is a long-biased sector long/short equity fund investing in the global healthcare market. The investment process is based on fundamental analysis. In addition to this, the fund manager uses a proprietary scientific investment approach receiving scientific advice from external experts from all fields of medicine. Healthcare hedge fund Rhenman still buoyant on sector, as flagship strategy advances in January Submitted By Hugh Leask | 09/02/2021 - 4:32pm The healthcare sector can expect a “reasonably stable political environment” this year, according to healthcare-focused specialist hedge fund Rhenman & Partners Asset Management, whose buoyant stance comes after its flagship strategy finished The trio behind the fund are Henrik Rhenman, who has more than 15 years' experience of managing healthcare funds and is also chief investment officer, Göran Nordström, the former chief executive of Carnegie Asset Management, and myself, a former portfolio strategist at Fidelity Investments.